15.85
-0.15
(-0.94%)
At close: January 10 at 4:00:02 PM EST
15.98
+0.13
+(0.82%)
After hours: 7:59:17 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
946,000.00
799,000.00
858,000.00
2,458,000.00
2,187,000.00
Investing Cash Flow
-298,000.00
-260,000.00
-420,000.00
-837,000.00
-258,000.00
Financing Cash Flow
-363,000.00
-569,000.00
-433,000.00
-977,000.00
-2,175,000.00
End Cash Position
699,000.00
693,000.00
706,000.00
737,000.00
12,000.00
Capital Expenditure
-300,000.00
-261,000.00
-427,000.00
-488,000.00
-255,000.00
Issuance of Debt
1,036,000.00
80,000.00
--
9,470,000.00
1,512,000.00
Repayment of Debt
-1,047,000.00
-338,000.00
-108,000.00
-1,624,000.00
--
Free Cash Flow
646,000.00
538,000.00
431,000.00
1,970,000.00
1,932,000.00
12/31/2020 - 5/14/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRK Merck & Co., Inc.
99.25
-0.60%
GSK GSK plc
33.09
-1.96%
BMY Bristol-Myers Squibb Company
55.83
-1.73%
NVS Novartis AG
99.08
-1.14%
SNY Sanofi
48.73
-1.02%
GILD Gilead Sciences, Inc.
89.88
+0.83%
AMGN Amgen Inc.
262.23
-0.75%
ABBV AbbVie Inc.
175.17
-1.87%
AZN AstraZeneca PLC
67.01
+0.65%
PFE Pfizer Inc.
26.72
-0.52%